ASHPOfficial is the premier podcast of ASHP and the collective voice of our 50,000 members in health-system pharmacy. Through interviews and discussions with pharmacy thought leaders, ASHPOfficial will explore issues related to public health, medication use, and supporting the professional practice of pharmacists in hospitals, health systems, ambulatory clinics, and other settings. To learn more about ASHP, please visit ashp.org.
Episodes
Sunday Nov 28, 2021
Sunday Nov 28, 2021
Join our content matter expert from Section of Ambulatory Care Practitioners at the 2020 Midyear Clinical Meeting as they compare appropriate antithrombotic regimens for patients with and without atrial fibrillation who have recently undergone transcatheter aortic valve replacement (TAVR), evaluate the role of dual antiplatelet therapy (DAPT) in patients who have recently undergone TAVR and summarize the prevention and treatment of subclinical leaflet thrombosis in these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.